• Home
  • About Us
    • Our Company
    • Our Leadership Team
    • Board of Directors
  • Tobacco Franchise
    • VLN®
    • Clinical Studies & Commentaries
  • Hemp/Cannabis Franchise
  • News
  • Investors
    • Overview
    • New Investor / Latest Resources
    • Events
    • News
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Corporate Governance
    • Annual Reports
    • FAQs
  • Contact Us

Press Releases

Investors

Investors

  • Overview
  • New Investor / Latest Resources
  • Events
  • News
    • Press Releases
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Trades
  • SEC Filings
  • Analyst Coverage
  • Corporate Governance
  • Annual Reports
  • FAQs
  • News

  • Press Releases
Jun 22, 2011 4:26am EDT

22nd Century Files Investigational New Drug Application and Fast Track Request for X-22; Phase II-B Clinical Trial to Commence Immediately Upon FDA Clearance

Jun 08, 2011 9:42am EDT

22nd Century Doubles Acres Planted of Proprietary Tobacco; New Crop Will Increase Tobacco Inventory for Approximately $90 Million in Potential Sales of Finished Products

May 16, 2011 4:00am EDT

22nd Century Group Files First Quarter Report, Engages Redington, Inc. as Investor Relations Firm

Apr 22, 2011 10:10am EDT

Company Profile for 22nd Century Group, Inc.

RSS
  • Prev
    • 1...
    • 26
    • 27
    • 28
    • 29
    • 30
    • 31
    • 32
    • 33
    • 34
    • 35
    • Email Alerts
    • Contact
    • RSS News Feed
    © 2022 22nd Century Group, Inc. All Rights Reserved.
    Privacy Policy / CCPA Disclaimer Sitemap